Aldaqadossi Hussein A, Shaker Hossam, Saifelnasr Mohammed, Gaber Mohammed
Fayoum Faculty of Medicine, Fayoum, Egypt.
Tanta Faculty of Medicine, Tanta, Egypt.
Arab J Urol. 2015 Jun;13(2):107-11. doi: 10.1016/j.aju.2015.02.007. Epub 2015 Mar 9.
To evaluate the efficacy of tamsulosin for promoting ureteric stone expulsion in children, based on the confirmed efficacy of tamsulosin as a medical expulsive therapy in adults.
From February 2010 to July 2013, 67 children presenting with a distal ureteric stone of <1 cm as assessed on unenhanced computed tomography were included in the study. The patients were randomised into two groups, with group 1 (33 patients) receiving tamsulosin 0.4 mg and ibuprofen, and group 2 (34) receiving ibuprofen only. They were followed up for 4 weeks. Endoscopic intervention was indicated for patients with uncontrolled pain, recurrent urinary tract infection, hypersensitivity to tamsulosin and failure of stone passage after 4 weeks of conservative treatment.
Sixty-three patients completed the study. There were no statistically significant differences between the groups in patient age, body weight and stone size, the mean (SD) of which was 6.52 (1.8) mm in group 1 vs. 6.47 (1.79) mm in group 2 (P = 0.9). The mean (SD) time to stone expulsion in group 1 was 7.7 (1.9) days, vs. 18 (1.73) days in group 2 (P < 0.001). The analgesic requirement (mean number of ketorolac injections) in group 1 was significantly less than in group 2, at 0.55 (0.8) vs. 1.8 (1.6) (P < 0.001). The stone-free rate was 87% in group 1 and 63% in group 2 (P = 0.025).
Tamsulosin used as a medical expulsive therapy for children with ureteric stones is safe and effective, as it facilitates spontaneous expulsion of the stone.
基于坦索罗辛作为药物排石疗法在成人中已得到证实的疗效,评估其促进儿童输尿管结石排出的疗效。
2010年2月至2013年7月,67例经非增强计算机断层扫描评估为远端输尿管结石直径<1 cm的儿童纳入本研究。患者被随机分为两组,第1组(33例患者)接受坦索罗辛0.4 mg和布洛芬治疗,第2组(34例)仅接受布洛芬治疗。对他们进行了4周的随访。对于疼痛无法控制、复发性尿路感染、对坦索罗辛过敏以及保守治疗4周后结石仍未排出的患者,需进行内镜干预。
63例患者完成了研究。两组患者的年龄、体重和结石大小差异无统计学意义,第1组的平均(标准差)结石大小为6.52(1.8)mm,第2组为6.47(1.79)mm(P = 0.9)。第1组结石排出的平均(标准差)时间为7.7(1.9)天,第2组为18(1.73)天(P < 0.001)。第1组的镇痛需求(酮咯酸注射的平均次数)显著少于第2组,分别为0.55(0.8)次和1.8(1.6)次(P < 0.001)。第1组的无石率为87%,第2组为63%(P = 0.025)。
坦索罗辛作为输尿管结石患儿的药物排石疗法是安全有效的,因为它有助于结石自然排出。